OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Improving these processes involves modifying various factors, including cell line engineering, media composition, and bioreactor environments. A key goal is to increase antibody production while lowering production